• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 20, 2004

View Archived Issues

Rheumatoid arthritis therapy modifies autoimmune response

Read More

Novel ocular hypotensive agent BVT-28949 effective in monkeys

Read More

Effective use of immediate-release and modified-release indiplon to treat insomnia

Read More

Potassium channel modulation blocks insulin release

Read More

Data support improved profile of cisapride analogue ATI-7505

Read More

Discovery of novel diamantane derivatives with antitumor activity and low toxicity

Read More

Evidence supports a better safety profile of viramidine in hepatitis C patients

Read More

Reduced esophageal motility found with baclofen in healthy volunteers

Read More

Phase III trial of Xolair begins in pediatric allergic asthma patients

Read More

FDA grants priority review to fixed dose combination of Viread and Emtriva

Read More

Ark to provide EG-005 on compassionate-use basis for patients ending phase II lipodystrophy trial

Read More

Largest-ever trial begins to evaluate efficacy and safety of IGIV for CIDP

Read More

Agenix updates ThromboView program

Read More

Aventis receives priority review designation for the expanded use of Taxotere

Read More

Aventis ends agreement with DeveloGen for DiaPep277

Read More

Pozen and GSK move new migraine treatment into phase III

Read More

Chemokine Therapeutics submits IND for CTCE-0214

Read More

Juvaris receives phase I SBIR grant for development of P. aeruginosa vaccine

Read More

Phase III trial begins with tifacogin as treatment for severe community-acquired pneumonia

Read More

Patient enrollment commences in phase I/II trial of E2F decoy

Read More

Elan and Biogen Idec to file for approval of Antegren for Crohn's disease in Europe

Read More

Elan and Vernalis finalize agreement regarding Frova

Read More

Idenix reports phase I/II clinical trial data for NM-283 as treatment of hepatitis C

Read More

Data on anidulafungin activity, pharmacokinetics presented

Read More

Olpadronate increases bone strength in mice

Read More

Cinacalcet controls parathyroid hormone in kidney disease patients

Read More

More erythromycin antibiotics in early development at Enanta

Read More

Fournier presents new hypoglycemic and hypolipidemic agents

Read More

Novel CRF antagonists prepared and tested at BMS

Read More

Bayer describes novel guanylate cyclase activators with utility in cognition disorders

Read More

Dual PPARalpha/PPARgamma agonists and their use claimed by Merck KGaA

Read More

Roche scientists identify new PPARalpha/PPARgamma agonists

Read More

New glucokinase activators covered by Roche patent

Read More

GSK researchers design dopamine/5-HT receptor ligands for schizophrenia and drug abuse

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe